EUVIMEDEUVIMED entdecken
Kohortenstudie

Alternative beta-hCG follow-up protocols after single-dose methotrexate therapy for ectopic pregnancy: A retrospective cohort study

Ala Aiob, Raneen Abu Shqara, Susana Mustafa Mikhail, Avishalom Sharon, Marwan Odeh, Lior Lowenstein

European Journal of Obstetrics & Gynecology and Reproductive Biology · 2023

DOI: 10.1016/j.ejogrb.2023.03.024 ↗

Kurz gefasst

Kohortenstudie in der Zeitschrift European Journal of Obstetrics & Gynecology and Reproductive Biology, 2023. Verfasst von Ala Aiob und 5 weiteren Autor:innen. Beteiligte Einrichtung: Department of Obstetrics and Gynecology, Galilee Medical Center, Nahariya, Israel; Azrieli Faculty of Medicine, Bar Ilan University, Safed, Israel. E…. Hauptthemen laut MEDLINE: Pregnancy, Ectopic, Abortifacient Agents, Nonsteroidal. Die Arbeit wurde bisher 6-mal zitiert (Crossref) und nennt 20 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

OBJECTIVE: This study assessed the relevance of reductions in beta-hCG levels between days 0 and 4 and between days 0 and 7 after single-dose methotrexate therapy, and the success of the therapy. STUDY DESIGN: A retrospective cohort study of 276 women diagnosed with ectopic pregnancy who received methotrexate as first-line treatment. Demographics, sonographic findings and beta-hCG levels and indexes were compared between women with successful and failed treatment outcomes. RESULTS: The median beta-hCG levels were lower in the success than the failure group on days 0, 4 and 7: 385 (26-9134) vs. 1381 (28-6475), 329 (5-6909) vs. 1680 (32-6496) and 232 (1-4876) vs. 1563 (33-6368), respectively, P < 0.001 for all. The best cut-off for the change in beta-hCG level from day 0 to 4 was a 19% decrease; the sensitivity was 77.0% and specificity 60.0%, positive predictive value (PPV) was 85% CI 95 [78.7.1%-89.9%]. The best cut-off for the change in beta-hCG level from day 0 to 7 was a 10% decrease; the sensitivity was 80.1% and specificity 70.8%, PPV was 90.5% CI 95 [85.1%-94.5%]. CONCLUSIONS: A decrease of 10% in beta-hCG between days 0 and 7 and 19% between days 0 and 4 can be used as a predictor of treatment success in specific cases.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Pregnancy, EctopicAbortifacient Agents, NonsteroidalPregnancyHumansFemaleMethotrexateChorionic Gonadotropin, beta Subunit, HumanRetrospective StudiesFollow-Up StudiesTreatment Outcome

Stichwörter der Autor:innen

Beta human chorionic gonadotropinExtrauterine pregnancyMethotrexateTubal pregnancy

Substanzen

MethotrexateChorionic Gonadotropin, beta Subunit, HumanAbortifacient Agents, Nonsteroidal

Autor:innen und Institutionen

  • Department of Obstetrics and Gynecology, Galilee Medical Center, Nahariya, Israel; Azrieli Faculty of Medicine, Bar Ilan University, Safed, Israel. Electronic address: Ala.Aiob@gmail.com.
  • Department of Obstetrics and Gynecology, Galilee Medical Center, Nahariya, Israel; Azrieli Faculty of Medicine, Bar Ilan University, Safed, Israel.

Zitieren

APA

Aiob, A., Shqara, R. A., Mikhail, S. M., Sharon, A., Odeh, M., & Lowenstein, L. (2023). Alternative beta-hCG follow-up protocols after single-dose methotrexate therapy for ectopic pregnancy: A retrospective cohort study. European Journal of Obstetrics & Gynecology and Reproductive Biology. https://doi.org/10.1016/j.ejogrb.2023.03.024

Vancouver

Aiob A, Shqara RA, Mikhail SM, Sharon A, Odeh M, Lowenstein L. Alternative beta-hCG follow-up protocols after single-dose methotrexate therapy for ectopic pregnancy: A retrospective cohort study. European Journal of Obstetrics & Gynecology and Reproductive Biology. 2023. doi:10.1016/j.ejogrb.2023.03.024

BibTeX
@article{Aiob2023,
  author = {Aiob, Ala and Shqara, Raneen Abu and Mikhail, Susana Mustafa and Sharon, Avishalom and Odeh, Marwan and Lowenstein, Lior},
  title = {Alternative beta-hCG follow-up protocols after single-dose methotrexate therapy for ectopic pregnancy: A retrospective cohort study},
  journal = {European Journal of Obstetrics & Gynecology and Reproductive Biology},
  year = {2023},
  doi = {10.1016/j.ejogrb.2023.03.024}
}
Kostenlos starten →